Patents by Inventor Narayan Subhash Chakor

Narayan Subhash Chakor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AN INDUSTRIAL PROCESS FOR RESOLUTION OF CHLOCYPHOS
    Publication number: 20220389040
    Abstract: The present invention relates to a process for resolution of Chlocyphos of Formula (I) to obtain corresponding (S)- or (R)-isomers. The present invention further relates to a process of obtaining (S)-Chlocyphos using (R)-(+)-?-methylbenzylamine and (R)-Chlocyphos using (S)-?-methylbenzylamine. The said resolution process provides the corresponding isomer with chiral purity more than 98%.
    Type: Application
    Filed: October 13, 2020
    Publication date: December 8, 2022
    Applicant: Hikal Limited
    Inventors: Rakesh Ramesh GANORKAR, Sudhir NAMBIAR, Narayan Subhash CHAKOR, H.D. GURUPADASWAMY, Shamrao Bapurao SHELAR
  • Fused triterpene compounds and uses thereof
    Patent number: 10105373
    Abstract: The present invention discloses fused triterpene compounds, represented by the compounds of Formula I (as described herein), processes for their preparation, pharmaceutical compositions comprising the said compounds, their use as retinoid-related orphan receptors gamma (ROR?) modulators and/or interleukin-17 (IL-17) inhibitors and methods for their use in the treatment of a disease or a disorder mediated by ROR? and/or IL-17.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: October 23, 2018
    Assignee: PIRAMAL ENTERPRISES LIMITED
    Inventors: Rajiv Sharma, Namdev Narayan Borhade, Narayan Subhash Chakor, Hitesh Devchandbhai Mistry
  • FUSED TRITERPENE COMPOUNDS AND USES THEREOF
    Publication number: 20170119795
    Abstract: The present invention discloses fused triterpene compounds, represented by the compounds of Formula I (as described herein), processes for their preparation, pharmaceutical compositions comprising the said compounds, their use as retinoid-related orphan receptors gamma (ROR?) modulators and/or interleukin-17 (IL-17) inhibitors and methods for their use in the treatment of a disease or a disorder mediated by ROR? and/or IL-17.
    Type: Application
    Filed: June 24, 2015
    Publication date: May 4, 2017
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Rajiv SHARMA, Namdev Narayan BORHADE, Narayan Subhash CHAKOR, Hitesh Devchandbhai MISTRY
  • HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS
    Publication number: 20160354430
    Abstract: This invention relates to a method of treatment of cancer comprising administering compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyl, Saji David GEORGE, Shailendra SONAWANE, Narayan Subhash CHAKOR, Abhijit ROYCHOWDHURY, Rajiv SHARMA
  • Hexadepsipeptide analogues as anticancer compounds
    Patent number: 9475842
    Abstract: This invention relates to an isolated compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of the compound of Formula (1) by fermentation of the fungal strain of Actinomycetes (PM0895172/MTCC 684), pharmaceutical compositions comprising the compound of Formula (1) as the active ingredient; and use of the compounds or composition containing them in the treatment of cancer.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: October 25, 2016
    Assignee: Piramal Enterprises Limited
    Inventors: Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyl, Saji David George, Shailendra Sonawane, Narayan Subhash Chakor, Abhijit Roychowdhury, Rajiv Sharma
  • HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS
    Publication number: 20150080312
    Abstract: This invention relates to an isolated, compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of the compound of Formula (1) by fermentation of the fungal strain of Actinomycetes (PM0895172/MTCC 684), pharmaceutical compositions comprising the compound of Formula (1) as the active ingredient; and use of the compounds or composition containing them in the treatment of cancer.
    Type: Application
    Filed: May 6, 2013
    Publication date: March 19, 2015
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyl, Saji David George, Shailendra Sonawane, Narayan Subhash Chakor, Abhijit Roychowdhury, Rajiv Sharma